Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +347 | +2.19% | $0.00 | 16.2K | Sep 1, 2023 | Direct | F1 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$47.4K | -120 | -0.74% | $394.60 | 16.1K | Sep 1, 2023 | Direct | |
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +253 | +1.57% | $0.00 | 16.4K | Sep 1, 2023 | Direct | F1 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$34.7K | -88 | -0.54% | $394.60 | 16.3K | Sep 1, 2023 | Direct | |
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +361 | +2.22% | $0.00 | 16.6K | Sep 2, 2023 | Direct | F1 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$49.3K | -125 | -0.75% | $394.60 | 16.5K | Sep 2, 2023 | Direct | |
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +495 | +3% | $0.00 | 17K | Sep 3, 2023 | Direct | F1 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$67.9K | -172 | -1.01% | $394.60 | 16.8K | Sep 3, 2023 | Direct | |
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +600 | +3.56% | $0.00 | 17.4K | Sep 4, 2023 | Direct | F1 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$82.1K | -208 | -1.19% | $394.60 | 17.2K | Sep 4, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO | Restricted Stock Units | Award | $0 | +2K | $0.00 | 2K | Sep 1, 2023 | Bio-Rad A Common Stock | 2K | $0.00 | Direct | F2, F3 | |
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -347 | -25% | $0.00 | 1.04K | Sep 1, 2023 | Bio-Rad A Common Stock | 347 | $0.00 | Direct | F2, F4 |
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -253 | -33.29% | $0.00 | 507 | Sep 1, 2023 | Bio-Rad A Common Stock | 253 | $0.00 | Direct | F2, F5 |
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -361 | -50% | $0.00 | 361 | Sep 2, 2023 | Bio-Rad A Common Stock | 361 | $0.00 | Direct | F2, F6 |
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -495 | -50% | $0.00 | 495 | Sep 3, 2023 | Bio-Rad A Common Stock | 495 | $0.00 | Direct | F2, F7 |
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -600 | -100% | $0.00* | 0 | Sep 4, 2023 | Bio-Rad A Common Stock | 600 | $0.00 | Direct | F2, F8 |
Id | Content |
---|---|
F1 | Shares of Class A common stock acquired on the vesting of restricted stock units. |
F2 | Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. |
F3 | The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
F4 | On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F5 | On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F6 | On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F7 | On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |
F8 | On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |